HELSINKI, May 23, 2024
/PRNewswire/ -- TrueMed, the leading provider of
anti-counterfeiting technology solutions for pharmaceuticals,
announces its selection by a top 10 global pharmaceutical with
medications spanning across oncology, cardiovascular, respiratory,
vaccines, and more.
The partnership comes at a critical time, as counterfeit
medications become increasingly sophisticated, posing a grave risk
to patient safety worldwide. TrueMed's advanced AI technology is
uniquely capable of identifying the subtle indicators of
counterfeit products, providing a level of detection precision that
far exceeds traditional methods.
A key innovation of this collaboration is the decentralization
of the authentication process. TrueMed's technology will be
deployed directly to frontline staff, empowering local
investigators with the tools to quickly and accurately analyze
suspicious samples. This approach not only expedites the
investigative process but also significantly increases its
efficiency and volume, ensuring a more robust defense against
counterfeit medications.
Moreover, the adoption of TrueMed's AI solutions by the leading
pharmaceutical is expected to reduce the reliance on physical
security features in packaging. This shift promises to lower costs
and simplify packaging processes, aligning with environmental
sustainability goals without compromising the integrity of the
medications.
"This partnership isn't just about technology; it's about taking
a stand for the safety of patients everywhere. The counterfeiters
are getting smarter, using advanced methods to deceive us. That's
why it's critical we outsmart them at every turn. Our AI isn't just
a collection of algorithms – it's a powerful ally for the people on
the ground, helping them catch what the naked eye can easily miss.
Together, we're making a real difference in the fight against fake
meds," commented Jyrki Berg, CEO
TrueMed.
For additional insights into TrueMed's advanced AI-based
anti-counterfeiting solutions, please visit www.truemedinc.com.
About TrueMed.
TrueMed is a leading provider of anti-counterfeiting technology
solutions. The company's AI-enabled platform uses cutting-edge
technology to analyze and identify potential counterfeit products,
allowing companies to quickly and efficiently protect their brands
and their customers.
For more information, please visit truemedinc.com.
Contact: Tuomas Kannas, TrueMed, 378122@email4pr.com, +358
50 568 0782
View original content to download
multimedia:https://www.prnewswire.com/news-releases/truemeds-ai-platform-selected-by-leading-global-pharmaceutical-to-advance-counterfeit-investigations-302154213.html
SOURCE TrueMed